Role of infection in irritable bowel syndrome

Journal of Gastroenterology

Volumn 42, Issue SUPPL.17, 2007, Pages 41-47

  Spiller, Robin C ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Infection; Inflammation; Irritable bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; PROBIOTIC AGENT; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN TRANSPORTER;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM LONGUM INFANTIS; CAMPYLOBACTER JEJUNI; CYTOKINE PRODUCTION; DEPRESSION; DISEASE SEVERITY; ENTEROCHROMAFFIN CELL; GASTROENTERITIS; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HYPOCHONDRIASIS; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION COMPLICATION; INFLAMMATORY INFILTRATE; INTESTINE BIOPSY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LONG TERM CARE; LYMPHOCYTE COUNT; NEUROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK FACTOR; SALMONELLA; SALMONELLOSIS; SEROTONIN METABOLISM; SHIGELLA; SHIGELLOSIS; SYMPTOMATOLOGY;

BACTERIAL INFECTIONS; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; SEROTONIN;

EID: 33846423499     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1925-8     Document Type: Article

References (51)

1. RC Spiller D Jenkins JP Thornley JM Hebden T Wright M Skinner 2000 Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 47 804-11 11076879 10.1136/gut.47.6.804 1:STN:280:DC%2BD3M%2FmsVCquw%3D%3D
2. S Sanovic DP Lamb MG Blennerhassett 1999 Damage to the enteric nervous system in experimental colitis Am J Pathol 155 1051-7 10514387 1:STN:280:DyaK1MvksFehsA%3D%3D
3. KR Neal J Hebden R Spiller 1997 Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients Br Med J 314 779-82 1:STN:280:ByiB3sngvVY%3D
4. WG Thompson GF Longstreth DA Drossman KW Heaton EJ Irvine SA Muller-Lissner 1999 Functional bowel disorders and functional abdominal pain Gut 45 Suppl 2 II43-7 10457044
5. SP Dunlop D Jenkins KR Neal RC Spiller 2003 Clinical and histological features of post-infectious IBS: Relative importance of enterochromaffin cell hyperplasia, anxiety and depression Gastroenterology 125 1651-9 14724817 10.1053/j.gastro.2003.09.028
6. SP Dunlop D Jenkins RC Spiller 2003 Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome Am J Gastroenterol 98 1578-83 12873581 10.1111/j.1572-0241.2003.07542.x
7. LH Wang XC Fang GZ Pan 2004 Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis Gut 53 1096-101 15247174 10.1136/gut.2003.021154 1:CAS:528:DC%2BD2cXmvVehtLg%3D
8. JP Thornley D Jenkins K Neal T Wright J Brough RC Spiller 2001 Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome J Infect Dis 184 606-9 11474430 10.1086/322845 1:STN:280:DC%2BD3Mvks1KhtA%3D%3D
9. SP Dunlop D Jenkins KR Neal RC Spiller 2003 Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS Gastroenterology 125 1651-9 14724817 10.1053/ j.gastro.2003.09.028
10. J Wheatcroft D Wakelin A Smith CR Mahoney G Mawe R Spiller 2005 Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction Neurogastroenterol Motil 17 863-70 16336502 10.1111/j.1365-2982.2005.00719.x 1:STN:280:DC%2BD2MnlvVKltQ%3D%3D
11. KA Gwee YL Leong C Graham MW McKendrick SM Collins SJ Walters 1999 The role of psychological and biological factors in postinfective gut dysfunction Gut 44 400-6 10026328 1:STN:280:DyaK1M7lt1WgtA%3D%3D
12. SP Dunlop D Jenkins RC Spiller 2004 Age-related decline in rectal mucosal lymphocytes and mast cells Eur J Gastroenterol Hepatol 16 1011-5 15371925 10.1097/00042737-200410000-00010
13. AS Zigmond RP Snaith 1983 The hospital anxiety and depression scale Acta Psychiatr Scand 67 361-70 6880820 1:STN:280:BiyB2sbhtVw%3D
14. KA Gwee JC Graham MW McKendrick SM Collins JS Marshall SJ Walters 1996 Psychometric scores and persistence of irritable bowel after infectious diarrhoea Lancet 347 150-3 8544549 10.1016/S0140-6736(96)90341-4 1:STN:280:BymC3sfivVc%3D
15. M Kidd IM Modlin GN Eick MC Champaneria 2006 Isolation, functional characterization and transcriptome of mastomys ileal enterochromaffin cells Am J Physiol Gastrointest Liver Physiol 291 G778-91 16455786 10.1152/ajpgi.00552.2005 1:CAS:528:DC%2BD28Xht1GnsL%2FM
16. W Atkinson S Lockhart PJ Whorwell B Keevil LA Houghton 2006 Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome Gastroenterology 130 34-43 16401466 10.1053/j.gastro.2005.09.031 1:CAS:528:DC%2BD28XhtFCgtb8%3D
17. SP Dunlop NS Coleman E Blackshaw AC Perkins G Singh CA Marsden 2005 Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin Gastroenterol Hepatol 3 349-57 15822040 10.1016/ S1542-3565(04)00726-8 1:CAS:528:DC%2BD2MXktVSisr4%3D
18. MD Coates CR Mahoney DR Linden JE Sampson J Chen H Blaszyk 2004 Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 126 1657-64 15188158 10.1053/j.gastro.2004.03.013 1:CAS:528:DC%2BD2cXlsFaqsrg%3D
19. C Andrews M Camilleri AE Bharucha PJ Carlson I Ferber D Stephens 2006 Serotonin-transporter (SERT) polymorphism genotype and SERT expression in mucosal biopsies of patients with irritable bowel syndrome Gastroenterology 125 A61
20. A Caspi K Sugden TE Moffitt A Taylor IW Craig H Harrington 2003 Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene Science 301 386-9 12869766 10.1126/science.1083968 1:CAS:528:DC%2BD3sXls1ygsrw%3D
21. HJ Lee MS Lee RH Kang H Kim SD Kim BS Kee 2005 Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder Depress Anxiety 21 135-9 15965993 10.1002/ da.20064 1:CAS:528:DC%2BD2MXos1GhsrY%3D
22. A Yeo P Boyd S Lumsden T Saunders A Handley M Stubbins 2004 Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women Gut 53 1452-8 15361494 10.1136/gut.2003.035451 1:CAS:528:DC%2BD2cXovFOqu74%3D
23. DR Linden SL White K Foley LD Stirling GM Mawe 2005 Evidence for a distinct mechanism of serotonin transporter gene regulation in the human intestine involving a novel splice variant Gastroenterology 128 A59
24. VS Chadwick W Chen D Shu B Paulus P Bethwaite A Tie 2002 Activation of the mucosal immune system in irritable bowel syndrome Gastroenterology 122 1778-83 12055584 10.1053/gast.2002.33579
25. G Barbara V Stanghellini R De Giorgio C Cremon GS Cottrell D Santini 2004 Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 126 693-702 14988823 10.1053/j.gastro.2003.11.055
26. KA Gwee SM Collins NW Read A Rajnakova Y Deng JC Graham 2003 Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome Gut 52 523-6 12631663 10.1136/ gut.52.4.523 1:CAS:528:DC%2BD3sXjtVKltLY%3D
27. F Galeazzi EM Haapala N van Rooijen BA Vallance SM Collins 2000 Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent Am J Physiol Gastrointest Liver Physiol 278 G259-65 10666050 1:CAS:528:DC%2BD3cXhsVOgs70%3D
28. Y Xia HZ Hu S Liu J Ren DH Zafirov JD Wood 1999 IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system J Clin Invest 103 1309-16 10225974 1:CAS:528:DyaK1MXivFans7s%3D
29. SP Dunlop JM Hebden J Naesdal L Olbe AC Perkins RC Spiller 2006 Abnormal intestinal permeability in subgroups of diarrhoea predominant irritable bowel syndromes Am J Gastroenterol 101 1288-94 16771951 10.1111/ j.1572-0241.2006.00672.x
30. JK Marshall M Thabane AX Garg W Clark J Meddings SM Collins 2004 Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario Aliment Pharmacol Ther 20 1317-22 15606393 10.1111/ j.1365-2036.2004.02284.x 1:STN:280:DC%2BD2cnjtVyktQ%3D%3D
31. E Campbell M Richards S Foley M Hastings P Whorwell Y Mahida 2006 Markers of inflammation in IBS: Increased permeability and cytokine production in diarrhoea-predominant subgroups Gastroenterology 130 A5110.1053/S0016-5085(06)00296-4
32. L O'Mahony J McCarthy P Kelly G Hurley F Luo K Chen 2005 Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles Gastroenterology 128 541-51 15765388 10.1053/j.gastro.2004.11.050
33. G Holtmann NJ Talley T Liebregts B Adam C Parow 2006 A placebo-controlled trial of itopride in functional dyspepsia N Engl J Med 354 832-40 16495395 10.1056/NEJMoa052639 1:CAS:528:DC%2BD28Xhsl2gs7Y%3D
34. TG Dinan EM Quigley SM Ahmed P Scully S O'brien L O'Mahony 2006 Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 130 304-11 16472586 10.1053/j.gastro.2005.11.033 1:CAS:528:DC%2BD28Xit1alu7w%3D
35. M Maes C Song A Lin R De Jongh A Van Gastel G Kenis 1998 The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety Cytokine 10 313-8 9617578 10.1006/cyto.1997.0290 1:CAS:528:DyaK1cXjsVGksLY%3D
36. L Chang 2004 Review article: Epidemiology and quality of life in functional gastrointestinal disorders Aliment Pharmacol Ther 20 Suppl 7 31-9 15521853 10.1111/j.1365-2036.2004.02183.x 1:CAS:528:DC%2BD2cXnsVehtg%3D%3D
37. DR Linden JX Chen MD Gershon KA Sharkey GM Mawe 2003 Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol 285 G207-16 12646422 1:CAS:528:DC%2BD3sXls1WmsLs%3D
38. F Cremonini S Delgado-Aros M Camilleri 2003 Efficacy of alosetron in irritable bowel syndrome: A meta-analysis of randomized controlled trials Neurogastroenterol Motil 15 79-86 12588472 10.1046/ j.1365-2982.2003.00389.x 1:STN:280:DC%2BD3s%2FnvVChtA%3D%3D
39. FL Christofi M Kim JE Wunderlich J Xue Z Suntres A Cardounel 2004 Endogenous adenosine differentially modulates 5-hydroxytryptamine release from a human enterochromaffin cell model Gastroenterology 127 188-202 15236185 10.1053/j.gastro.2004.04.070 1:CAS:528:DC%2BD2cXmsVShs70%3D
40. M Pimentel EJ Chow HC Lin 2003 Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study Am J Gastroenterol 98 412-9 12591062
41. SM Riordan CJ McIver BM Walker VM Duncombe TD Bolin MC Thomas 1996 The lactulose breath hydrogen test and small intestinal bacterial overgrowth Am J Gastroenterol 91 1795-803 8792701 1:STN:280:BymA1cvosVU%3D
42. AC Anand PS Reddy GS Saiprasad SK Kher 1997 Does non-dysenteric intestinal amoebiasis exist? Lancet 349 89-92 8996420 10.1016/ S0140-6736(96)06121-1 1:STN:280:ByiC2cbmtFY%3D
43. TS King M Elia JO Hunter 1998 Abnormal colonic fermentation in irritable bowel syndrome Lancet 352 1187-9 9777836 10.1016/S0140-6736(98)02146-1 1:STN:280:DyaK1cvkvFaltA%3D%3D
44. PR Maxwell E Rink D Kumar MA Mendall 2002 Antibiotics increase functional abdominal symptoms Am J Gastroenterol 97 104-8 11808932 10.1111/j.1572-0241.2002.05428.x 1:STN:280:DC%2BD38%2Fot1Cktw%3D%3D
45. B Sheil J McCarthy L O'Mahony MW Bennett P Ryan JJ Fitzgibbon 2004 Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis Gut 53 694-700 15082588 10.1136/gut.2003.027789 1:CAS:528:DC%2BD2cXktlKit7c%3D
46. EF Verdu SM Collins 2005 Irritable bowel syndrome and probiotics: From rationale to clinical use Curr Opin Gastroenterol 21 697-701 16220048 10.1097/01.mog.0000182861.11669.4d
47. R Penner RN Fedorak KL Madsen 2005 Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases Curr Opin Pharmacol 5 596-603 16214413 10.1016/j.coph.2005.06.009 1:CAS:528:DC%2BD2MXhtFKntrjP
48. PJ Whorwell L Altringer J Morel Y Bond L O'Mahony B Kiely 2005 Benefits associated with supplementation with an encapsulated probiotic preparation in subjects with irritable bowel syndrome Gastroenterology 128 A469
49. AP Weston WL Biddle PS Bhatia PB Miner Jr 1993 Terminal ileal mucosal mast cells in irritable bowel syndrome Dig Dis Sci 38 1590-5 8359068 10.1007/BF01303164 1:STN:280:ByyA28rjtlA%3D
50. M O'Sullivan N Clayton NP Breslin I Harman C Bountra A McLaren 2000 Increased mast cells in the irritable bowel syndrome Neurogastroenterol Motil 12 449-57 11012945 10.1046/j.1365-2982.2000.00221.x
51. JH Park PL Rhee G Kim JH Lee YH Kim JJ Kim 2006 Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome Neurogastroenterol Motil 18 539-46 16771769 10.1111/j.1365-2982.2006.00771.x 1:STN:280:DC%2BD28zlvVyrsg%3D%3D